High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?
Etual Espinosa-Cárdenas, Miriam Sánchez-García, Claudia Ramírez‐Rentería, Victoria Mendoza‐Zubieta, Ernesto Sosa, Moisés Mercado
Topics & Concepts
CabergolineAsymptomaticProlactinomaMedicineDiscontinuationInternal medicineBasal (medicine)UrologyGastroenterologyEndocrinologyDiabetes mellitusProlactinHormonePituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic TumorsNeuroendocrine Tumor Research Advances